How to Avoid Paxlovid Rebound? Prevention and Management Strategies
•
3 min read
According to reports submitted by Pfizer to the FDA, between 10% and 16% of people taking Paxlovid in clinical trials experienced a recurrence of symptoms or positive testing. Understanding this phenomenon is crucial for eligible patients who want to know how to avoid Paxlovid rebound and manage it if it occurs. The key is to manage expectations and follow established public health guidelines, rather than expecting complete prevention.
